We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$24.1B
AUM Growth
-$134M
Cap. Flow
-$2.11B
Cap. Flow %
-8.76%
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$157M
2
TMO icon
Thermo Fisher Scientific
TMO
+$135M
3
CRM icon
Salesforce
CRM
+$135M
4
IBM icon
IBM
IBM
+$130M
5
DELL icon
Dell
DELL
+$114M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$313M
2
AAPL icon
Apple
AAPL
+$207M
3
INTC icon
Intel
INTC
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$159M
5
CNC icon
Centene
CNC
+$152M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Technology 17.95%
3 Communication Services 13.61%
4 Consumer Discretionary 12.67%
5 Financials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRPC.U
1876
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
-47,501
Closed -$475K
TWNK
1877
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
-175,251
Closed -$2.51M
AAC.U
1878
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
-1,452,345
Closed -$14.5M
MDNA
1879
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
-19,300
Closed -$79K
RAD
1880
DELISTED
Rite Aid Corporation
RAD
-118,700
Closed -$2.43M
ANZUU
1881
DELISTED
Anzu Special Acquisition Corp I Units
ANZUU
-250,000
Closed -$2.5M
DBTX
1882
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
-11,522
Closed -$131K
QUOT
1883
DELISTED
Quotient Technology Inc
QUOT
-30,931
Closed -$505K
BKI
1884
DELISTED
Black Knight, Inc. Common Stock
BKI
-9,895
Closed -$732K
VRAY
1885
DELISTED
ViewRay, Inc.
VRAY
-49,330
Closed -$215K
NMTR
1886
DELISTED
9 Meters Biopharma
NMTR
-73,998
Closed -$1.73M
SDACU
1887
DELISTED
Sustainable Development Acquisition I Corp. Unit
SDACU
-555,519
Closed -$5.52M
XM
1888
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
-65,912
Closed -$2.17M
HEXO
1889
DELISTED
HEXO Corp. Common Shares
HEXO
-4,664
Closed -$422K
RXDX
1890
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-79,171
Closed -$1.45M
RUTH
1891
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-16,768
Closed -$417K
FNCH
1892
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
-1,578
Closed -$753K
APTO
1893
DELISTED
Aptose Biosciences, Inc.
APTO
-75
Closed -$201K
TCRR
1894
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-503,860
Closed -$11.1M
SUMO
1895
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-651,695
Closed -$12.3M
PRVB
1896
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-17,356
Closed -$182K
HZON
1897
DELISTED
Horizon Acquisition Corporation II
HZON
-55,820
Closed -$569K
IAA
1898
DELISTED
IAA, Inc. Common Stock
IAA
-37,441
Closed -$2.06M
RAAS
1899
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
-12,342
Closed -$508K
PDOT.U
1900
DELISTED
Peridot Acquisition Corp. II Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PDOT.U
-500,000
Closed -$4.97M

Similar funds

Marshall Wace North America's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.

  • Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
  • Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
  • Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
  • Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
  • Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
  • Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
  • Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.